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A B S T R A C T
We report on an adolescent female with Velocardiofacial syndrome (del(22)(q11.2)) and an epilepsy
phenotype resembling juvenile myoclonic epilepsy (JME). Clinically, the patient has characteristic signs
of both disorders. JME has been linked to several chromosomes, but has not been related to 22q11.2 and
is rarely observed in other genetic syndromes. We discuss possible explanations for a relationship
between the chromosomal aberration and epilepsy as well as the importance of precise delineation of
both epilepsy phenotypes and genetic defects in chromosomal disorders.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epileptic seizures are frequent in chromosomal disorders but
only occasionally represent as an explicit symptom. A few of these
disorders, however, are associated with speciﬁc seizure and EEG
patterns.1–3 Thus, it is assumed that causative chromosomal
aberrations offer the opportunity to identify genes which may be
involved in idiopathic epilepsies.2
Juvenile myoclonic epilepsy (JME) accounts for 4–11% of all
idiopathic epilepsies.4 Its main features are myoclonic morning
jerks, generalised seizures, absences, polyspike-wave patterns in
EEG and often photosensitivity. In the majority of cases age of
onset is between 12 and 18 years.
In JME-patients several autosomal genes have been reported to
show heterozygous (CACNB4, CLCN2, GABRA1, EFHC1)5–8 and in a
single case homozygous mutations (GABRD).9 Further loci have
been linked to chromosomes 5q, 6p and 15q.10–12 However, most
forms of JME seem to follow poly- or oligogenic inheritance.
The microdeletion 22q11.2 (incidence 1:4000) is associated
with cardiac defects, palatal anomalies, mental retardation,
dysmorphic features and sometimes psychosis. The resulting
phenotype is variably referred to as Velocardiofacial syndrome or
DiGeorge syndrome (OMIM 188400). About 20% of the patients* Corresponding author. Tel.: +41 44 387 6111; fax: +41 44 387 6249.
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doi:10.1016/j.seizure.2009.07.008suffer from epileptic seizures.13 Unfortunately, in most reports on
this syndrome the epilepsy phenotype is not further speciﬁed or
simply described as being symptomatic. Independently, hypocal-
cemia, fever and recurrent infections being frequent symptoms of
this syndrome are seizure-provoking factors as well. However,
despite considering such precipitating events, Kao et al.14 reported
a signiﬁcantly increased prevalence of unprovoked seizures in
individuals with del(22)(q11.2) and suggested generalised epi-
lepsy being a primary manifestation of the disorder.
So far, only a few studies focused on the potential connection
between certain epilepsy phenotypes and thismicrodeletion locus.
Coppola et al.15 described two patients with a del(22)(q11.2) and
an epilepsy resembling Rolandic epilepsy. Both patients had
sporadic Rolandic or occipital partial-onset seizures with clinical
and electroencephalographic features of benign idiopathic child-
hood epilepsy. In addition, familial partial epilepsy with variable
foci has been linked to 22q11–q12.16 Family members had mostly
nocturnal seizures arising from frontal, temporal, and occasionally
occipital foci. However, a second report could narrow down the
region to 22q12.17 Thus, the putative candidate gene for this
epilepsy disorder is not expected to be within, but distal to the
common microdeletion locus 22q11.2.
Furthermore, there were single reports on patients carrying the
deletion and presenting with atypical absences18 or generalised
seizures19, respectively.
Baralle et al.20 reported on amother and her sonwhich both had
a microdeletion 22q11.2. The mother presented with a tremor-likevier Ltd. All rights reserved.
Fig. 1. EEG with background activity around 8 Hz with a spontaneously occurring generalised spike-wave complex (A) and a generalised polyspike-wave complex during
15 Hz photic stimulation (B).
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since infancy. However, epileptic seizureswere not reported in this
family.
Here we report on a patient with both JME and a microdeletion
22q11.2 and discuss possible explanations for a relationship
between the two disorders and highlight the importance of a
precise delineation of both genetic defect and epilepsy phenotype.
2. Case report
Our female patient is the ﬁrst child of consanguineous
parents (second degree cousins). Family history further revealeda paternal female cousin with epilepsy, a paternal cousin
with trisomy 21 and several paternal family members that
developed dementia at old age. The mother developed an
abdominal teratoma after birth of the patient’s healthy
younger brother.
The patient was born by forceps at week 38 with intrauterine
growth retardation (2140 g, 47 cm). She suffered from a minor
ventricular septum defect. Psychomotor and speech delay were
reported as well as behavioural problems.
Myoclonic jerks symmetrically involving the arms without
disturbance of consciousness appeared for the ﬁrst time at the age
of 14 years and from then occurred nearly daily in the morning
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aura occurred at the same age.
Psychiatric problems became obvious one day after the second
generalised seizure. The girl was agitated and confused. She
suffered from sleep disturbances and acoustic hallucinations.
Antiepileptic pharmacotherapy proved to be difﬁcult. While
valproate completely suppressed tonic–clonic seizures and dimin-
ished myoclonic jerks, it led to signiﬁcant gain of weight.
Phenobarbital did not completely suppress seizures, whereas
lamotrigine worsened myoclonic jerks. Furthermore, the combina-
tion of antiepileptic and psychopharmacologic medication caused
side effects: low dose amisulpride caused parkinsonism, clozapine
severely enhanced myoclonic jerks, olanzapine seemed to enhance
psychiatric symptoms. Psychopharmocological treatment could
only modulate but never abolish psychiatric symptoms.
At the age of 18 years the patient’s height was 158 cm (P25),
the weight was 53 kg (P25–50). The patient had a long narrow
face with prominent chin, high nasal bridge, broad nasal root
and low set ears. Physical examination revealed rhinolalia
aperta, asymmetric and high palate, short velum palatinum,
deviation of the nasal septum and open mouth with dental
crowding. Fingers were long and slender. Neurological exam-
ination was unremarkable. There was no evidence for recurrent
infections in childhood. Serum calcium levels were normal
(2.35 mmol/l). Neuropsychological assessment revealed impair-
ment of speech functions and an IQ of 72. MRI of the brain was
normal. EEG revealed bilateral synchronous fronto-central
(poly) spike-wave discharges with photosensitivity similar to
EEG features in JME (Fig. 1).
Psychiatric examination revealed adequate orientation with
incoherent and intricate thinking, acoustic hallucinations and
apparent parathymia.
Based on the above mentioned features and psychiatric
symptoms we suspected a microdeletion 22q11.2, which was
conﬁrmed by FISH with probes from the critical DiGeorge region
(Vysis R) [46,XX,del(22)(q11.2)(D22S553-,D22S609-,D22S942-)].
To narrow down the breakpoints, MLPA (Multiplex Ligation-
dependent Probe Ampliﬁcation) was performed and revealed a
deletion of about 2.5 Mb (spanning the most commonly
deleted region and presumably containing 30 genes between
CDC45L to LZTR1).
3. Discussion
The epilepsy phenotype of our patient with the diurnal pattern
of myoclonias, generalised tonic–clonic seizures and pathologic
EEG with photosensitivity and generalised spike waves is
characteristic for JME. The age of onset and good response to
valproate further support this diagnosis, but molecular genetic
testing of the 5 known JME genes has not been performed. Other
features as cardiac defect, dysmorphic features and psychiatric
ﬁndings pointed to microdeletion 22q syndrome which was
veriﬁed by FISH and MLPA.
Although the syndrome’s phenotype is well known to include
epileptic seizures and epilepsy causing genes are predicted within
the 22q region14,17 the epilepsy phenotypes of patients carrying
the deletion are often described sparsely, a fact that hampers a
reliable evaluation of JME or JME-like epilepsy as perhaps being
characteristic for a del(22)(q11.2).
The rare descriptions of epilepsy phenotypes in this
syndrome include Rolandic epilepsy15, atypical absences18 and
generalised seizures14,19, whereas JME has so far not been
reported in this context. However, already Baralle et al.20
suggested myoclonic movement disorders to be part of the
microdeletion syndrome 22q11.2, but in that study no EEG
ﬁndings were mentioned, thus the nature of the myocloniasremains uncertain. No JME candidate gene is currently
suspected on 22q11.2.21,22 No ion channel genes have been
reported within the common deleted region.
It cannot be excluded that the co-occurrence of JME and
microdeletion 22q11.2 in our patient might simply be coin-
cidental. Both syndromes are known to be frequent genetic
disorders. The occurrence of epilepsy (not further speciﬁed) in a
patient’s cousin as well as parental consanguinity would also
support that interpretation. Because of normal serum calcium,
syndrome-associated facultative hypocalcemia seems not to be
responsible for epileptogenesis in this case. In our case a
syndrome-associated demasking of a latent predisposition to
seizures/JME due to hemizygosity of the microdeleted area could
be assumed aswell. A developinghyperthyroidismcan exacerbate
seizures in JME.23 Some similar processes might be triggered by
the chromosomal imbalance in our patient, althoughwe could not
yet identify a putative responsible gene. Moreover, in most
patients with both Velocardiofacial syndrome and seizures the
microdeletion was conﬁrmed by FISH. Thus, a potential correla-
tion of the microdeletion’s size and their epilepsy phenotype
remains unclear.
The precise delineation of the extent of a deletion by other
routine cytogenetic methods, such as MLPA rather than FISH,
might be a way to reliably correlate single epilepsy syndromes
with the deletion of certain genes and to identify novel epilepsy
genes. Furthermore, our case illustrates the importance of a precise
description of epilepsy phenotypes in chromosomal and other
genetic disorders in order to enable the identiﬁcation of putative
candidate genes causing idiopathic epilepsy by genotype–pheno-
type correlation.
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